Occudo Quantitative Strategies LP Integra Lifesciences Holdings Corp Transaction History

Occudo Quantitative Strategies LP

$501 Million
Q3 2024

A detailed history of Occudo Quantitative Strategies LP transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, Occudo Quantitative Strategies LP holds 42,580 shares of IART stock, worth $974,230. This represents 0.15% of its overall portfolio holdings.

Number of Shares

42,580

Holding current value

$974,230

% of portfolio

0.15%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$17.14 - $31.74 $729,821 - $1.35 Million	42,580 New	42,580 $773,000
Q4 2023 Feb 14, 2024	SELL	$34.21 - $44.59 $652,418 - $850,375	-19,071 Reduced 57.68%	13,991 $609,000
Q3 2023 Nov 14, 2023	BUY	$37.8 - $45.97 $1.25 Million - $1.52 Million	33,062 New	33,062 $1.26 Million
Q3 2022 Nov 14, 2022	BUY	$42.28 - $57.17 $2.35 Million - $3.18 Million	55,635 Added 190.45%	84,848 $3.59 Million
Q2 2022 Aug 15, 2022	SELL	$53.86 - $66.52 $212,208 - $262,088	-3,940 Reduced 11.88%	29,213 $1.58 Million
Q1 2022 May 16, 2022	BUY	$62.86 - $69.24 $128,674 - $141,734	2,047 Added 6.58%	33,153 $2.13 Million
Q4 2021 Feb 14, 2022	BUY	$62.47 - $73.25 $489,015 - $573,401	7,828 Added 33.63%	31,106 $2.08 Million
Q3 2021 Nov 15, 2021	BUY	$64.97 - $76.19 $263,843 - $309,407	4,061 Added 21.13%	23,278 $1.59 Million
Q2 2021 Aug 16, 2021	BUY	$66.79 - $76.63 $617,206 - $708,137	9,241 Added 92.63%	19,217 $1.31 Million
Q1 2021 May 14, 2021	BUY	$62.63 - $71.15 $41,836 - $47,528	668 Added 7.18%	9,976 $689,000
Q4 2020 Feb 16, 2021	BUY	$43.31 - $66.55 $403,129 - $619,447	9,308 New	9,308 $604,000

Others Institutions Holding IART

# of Institutions

242

Shares Held

75.3M

Call Options Held

585K

Put Options Held

21.3K

View Full List

About INTEGRA LIFESCIENCES HOLDINGS CORP

Ticker IART
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 83,518,200
Market Cap $1.91B
Description
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...

More about IART

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

News

Stay updated on Occudo Quantitative Strategies LP with notifications on news.

Account

Occudo Quantitative Strategies LP Integra Lifesciences Holdings Corp Transaction History